November 23rd 2024
A systematic review has found a potential link between edentulism and sleep apnea risk, although the authors said differences in study designs prohibited a meta-analysis.
Fauci and Panel Discuss Ongoing Challenges of the COVID-19 Pandemic, and Lessons Learned
October 19th 2020Coronavirus disease 2019 (COVID-19) is unlike any pandemic the world has experienced in the last 100 years, said Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, during his keynote.
Read More
Drs Mary Schroth and Jill Jarecki Discuss Treatments for All SMA Types
October 18th 2020Current treatment options spinal muscular atrophy (SMA) are available for all types of the disease regardless of motor strength, explained Jill Jarecki, PhD, chief scientific officer at Cure SMA, and Mary Schroth, MD, FAAP, FCCP, chief medical officer at Cure SMA.
Watch
Diabetes Risk Factors Dominate Top Causes of Global Mortality, Heighten COVID-19 Risks
October 15th 2020New data estimates from the Global Burden of Disease Study published by The Lancet illustrate how rising rates of chronic disease and public health failures compounded over decades to worsen the coronavirus disease 2019 (COVID-19) pandemic.
Read More
Dr J. Allen Meadows on Making the Decision to Put a Patient With Asthma on a Biologic
October 14th 2020Patients with severe asthma are good candidates for biologics, but choosing which biologic requires a shared decision-making conversation, said J. Allen Meadows, MD, president of the American College of Allergy, Asthma & Immunology.
Watch
What Factors Are Predictive of Lower ART Adherence Among Hispanic, Latino MSM?
October 13th 2020Younger age, poverty, recent drug use, depression, and unmet need for ancillary services were linked to lowered antiretroviral therapy (ART) adherence among HIV-positive Hispanic and Latino men who have sex with men (MSM).
Read More
Dr John Corboy Forecasts Promising Developments in Multiple Sclerosis
October 13th 2020Rebooting the immune system is an exciting approach, noted John Corboy, MD, professor of neurology, University of Colorado Denver, School of Medicine, and co-director of the Rocky Mountain MS Center at Anschutz Medical Campus.
Watch
Dr Jill Jarecki Discusses the Current Pipeline for SMA Therapies
October 11th 2020Combination treatments may be the future for treating patients with spinal muscular atrophy (SMA) at all stages and ages, explained Jill Jarecki, PhD, chief scientific officer at Cure SMA and research director of TREAT-NMD Neuromuscular Network.
Watch
Dr Blythe Adamson: Checkpoint Inhibitor Approval Linked to Uptick in Systemic End-of-Life Care
October 8th 2020Blythe Adamson, PhD, MPH, of Flatiron Health, discusses study results she presented at the annual American Society of Clinical Oncology meeting on the use of immune checkpoint inhibitors in end-of-life care
Watch
Dr Mary Schroth Discusses At-Home Treatment Options for Patients With SMA
October 4th 2020Increasing at-home access to care and treatment options for spinal muscular atrophy (SMA) proved to be helpful during the coronavirus disease 2019 (COVID-19) pandemic, explained Mary Schroth, MD, FAAP, FCCP, chief medical officer at Cure SMA.
Watch
Combo Treatment Bests Cemiplimab Monotherapy, Phase 2 Data Show
September 30th 2020Study results presented during the virtual European Society for Medical Oncology meeting demonstrated the superiority of cemiplimab (Libtayo) plus ipilimumab vs cemiplimab monotherapy for non–small cell lung cancer.
Read More
Ban on Gay Men Donating Corneas May No Longer Be Supported by Evidence
September 30th 2020Federal policy in the United States and Canada prohibiting men who have sex with another man (MSM) from donating corneas has led to the disqualification of between 1558 and 3217 cornea donations in 2018 alone, according to research published in JAMA Ophthalmology.
Read More
HSCT Viable for Children With Nonremission Acute Lymphoblastic Leukemia
September 30th 2020Research into children and adolescents with nonremission acute lymphoblastic leukemia (ALL) has been sparse, but a new analysis suggests that allogeneic hematopoietic stem cell transplantation is a good fit for some patients.
Read More